Litcius/Paper detail

Dose-dependent relation between metformin and the risk of hormone receptor-positive, her2-negative breast cancer among postmenopausal women with type-2 diabetes

Soumya Chikermane, Manvi Sharma, Susan Abughosh, Rajender R. Aparasu, Meghana V. Trivedi, Michael L. Johnson

2022Breast Cancer Research and Treatment16 citationsDOI

Topics & Concepts

MedicineBreast cancerMetforminInternal medicineOdds ratioOncologyCumulative doseCancerGynecologyEndocrinologyInsulinMetabolism, Diabetes, and CancerCancer Risks and FactorsCancer, Lipids, and Metabolism
Dose-dependent relation between metformin and the risk of hormone receptor-positive, her2-negative breast cancer among postmenopausal women with type-2 diabetes | Litcius